Ocutrx Technologies has released the OcuLenz AR/XR headset, which is designed to enhance visual clarity for people living with advanced age-related macular degeneration (AMD).
The AR/XR headset enhances vision by overlaying high-contrast, pixel-manipulated images onto the user's remaining viable field of view. The comapny says OcuLenz stands apart from traditional magnification aids because of its advanced pixel manipulation software. This system processes real-world video imagery and recreates it as an augmented reality display tailored to the user's remaining good vision.
By shifting pixels from the impaired central vision area to the more effective peripheral vision, OcuLenz compensates for the central vision loss characteristic of AMD. Its high-end optical engine delivers 2.5K resolution per eye and boasts a wide field of view—60 degrees horizontally, 40 degrees vertically, and 72 degrees diagonally—significantly surpassing the capabilities of typical AR headsets. This seamless integration of virtual and real-world elements creates a fully immersive and practical visual experience for the user.
Designed for functionality and mobility, the OcuLenz headset allows users to move freely and perform everyday tasks while wearing it. Its power comes from a Qualcomm Snapdragon XR2 processor, which provides speed, efficiency, and reliability. Additionally, with Wi-Fi and cellular connectivity, OcuLenz doubles as a versatile connectivity tool akin to a computer, tablet, or smartphone. This blend of technology not only enhances visual perception but also enriches the user's interaction with their environment, making it a groundbreaking tool in vision aid technology, according to Ocutrx.
"Having personally witnessed the profound effects of visual impairment within my own family, the inception of OcuLenz extends beyond technological innovation. It's a portal to a more vivid and fuller life for many," Co-founder Michael Freeman, who serves as CEO and CTO, said in a company news release. "Our device isn't merely an advancement in augmented reality tech; it's a substantial stride towards improving life's quality. We're making the once unvisible visible, opening up a world so many have been missing."
OcuLenz is set for commercial release in the first half of 2024, with Ocutrx actively working to secure coverage from Medicare and commercial insurance providers. Pre-orders of the OcuLenz for AMD are currently welcome at OculenzAMD.com.